All Cell Content

Bringing you the latest research surrounding the safety, efficacy and characterisation of cell & gene therapies, targeted approaches for cell line development, optimised cell media techniques, and more, through a range of Speaker Interviews, Industry Insights, and Expert Opinions.

Discussion Group Report
Oxford Global’s Discussion Groups provide a focused networking opportunity for a handful of like-minded experts on a monthly basis. Our February Discussion Group addressing ‘Cell Line Engineering’ was a tremendous success. The discussion brought together an exclusive panel of key opinion leaders to address the key factors behind the market’s growth, its priorities, future outlook, and challenges.
Edited by Tia Byer |
23 March 2022
Cell Line Development & Engineering
Insight Article
The need to demonstrate clonality for regulatory approval means that now more than ever, the industry must look towards streamlining and optimising clone selection efficacy. We sat down with senior representatives from Ichnos Sciences and Sanofi to learn how.
Edited by Tia Byer |
28 February 2022
Cell Line Development & Engineering
Written Q&A
Bobby Gaspar, President of Research and Chief Scientific Officer, Orchard Therapeutics
12 March 2020
Cell Line Development & Engineering

Search by Keyword

Filter by Subject Area

Filter by Content Type

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Member Community Login